Related Experiment Video
Updated: Jul 11, 2026

06:29
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Clinical variability and characteristic autoantibody profile in primary C1q complement deficiency.
G Vassallo1, R W Newton, S E Chieng
1Department of Paediatric Neurology, Booth Hall Children's Hospital, Manchester, M9 7AA, UK.
Rheumatology (Oxford, England)
|September 25, 2007
Summary
C1q deficiency, a rare complement cascade defect, presents diverse clinical features and specific autoantibodies. Early diagnosis is crucial for managing this severe immunodeficiency.
Area of Science:
- Immunology
- Genetics
Background:
- C1q deficiency is a rare inherited disorder affecting the complement cascade's early stages.
- It is associated with increased susceptibility to infections and autoimmune diseases.
Observation:
- A large, consanguineous Pakistani family exhibited C1q deficiency across multiple generations.
- Affected individuals, including a father and five sons, displayed varied clinical manifestations.
Findings:
- Clinical presentations ranged from asymptomatic to severe bacterial infections and lupus-like syndromes affecting skin, kidneys, or CNS.
- Characteristic autoantibodies included anti-Sm and anti-Ro, but not anti-dsDNA.
Implications:
- Recognizing the broad spectrum of C1q deficiency clinical and autoantibody profiles is vital.
- Accurate diagnosis and timely management are essential for this life-threatening immunodeficiency.
More Related Videos
Related Concept Videos
Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Antibody Actions
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Humoral Immune Responses
Overview

